Study Reveals Persistent Racial and Ethnic Disparities in Prevalence of Multiple Chronic Conditions
A Yale study found persistent racial and ethnic disparities in multimorbidity, which is defined as the presence of two or more concurrent chronic health conditions, in the United States over a 20-year period.
Yale researchers call for strategies to eliminate inequities in access to peripheral artery disease care among adults who share a Hispanic background
Adults who share a Hispanic background and who get hospitalized for symptoms of peripheral artery disease (PAD) are more likely to only receive care at later stages of their disease, and get their treatment through the emergency department instead of early stage disease care, elective care as compared with non-Hispanic white patients.
Major Funding Award Supports Yale Efforts to Address Maternal Health Inequities
A team of Yale researchers, working collaboratively with Yale New Haven Hospital, community partners and two regional hospitals, is exploring ways to improve health outcomes among pregnant and postpartum women in priority populations that have been historically underserved and experience systemic racism. A $20.4 million funding award from the Patient-Centered Outcomes Research Institute (PCORI) will support the study.
Poor and minority women face widening barriers to depression treatment
Megan Smith, DrPH, MPH, Associate Professor of Psychiatry and in the Child Study Center, is featured in a Connecticut Health Investigative Team story and podcast about depression in women and barriers to care.Source: Connecticut Health I-Team
Marietta Vázquez Appointed Vice Chair for Diversity for Pediatrics
The Department of Pediatrics is pleased to announce the appointment of Marietta Vázquez, MD, associate professor of pediatrics, as vice chair for diversity, equity and inclusion. Vazquez is a pediatric infectious diseases specialist at Yale School of Medicine.
Yale collaborates with FDA to advance diversity in clinical research
To promote scientific progress and diversity in clinical research, Yale School of Medicine and the U.S. Food and Drug Administration have agreed to collaborate on a range of far-reaching science-based initiatives. Through trainings, fellowships, internships, research, and education, the agreement will foster the exchange of scientific information between the institutions and improve human health.